Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for UG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.52M
March 31, 2026 0.6045M
December 31, 2025 0.3305M
September 30, 2025 1.011M
June 30, 2025 0.3032M
March 31, 2025 0.3221M
December 31, 2024 0.2693M
September 30, 2024 1.229M
June 30, 2024 1.324M
March 31, 2024 0.6441M
December 31, 2023 1.128M
September 30, 2023 1.165M
June 30, 2023 0.4347M
March 31, 2023 0.4176M
December 31, 2022 0.6247M
September 30, 2022 0.7359M
June 30, 2022 1.137M
March 31, 2022 0.0274M
December 31, 2021 1.664M
September 30, 2021 1.031M
June 30, 2021 1.627M
March 31, 2021 0.9902M
December 31, 2020 0.6725M
September 30, 2020 -0.2618M
June 30, 2020 1.896M
Date Value
March 31, 2020 1.287M
December 31, 2019 0.8491M
September 30, 2019 0.9842M
June 30, 2019 1.111M
March 31, 2019 1.532M
December 31, 2018 1.042M
September 30, 2018 1.192M
June 30, 2018 1.046M
March 31, 2018 1.670M
December 31, 2017 0.7779M
September 30, 2017 1.185M
June 30, 2017 1.154M
March 31, 2017 0.8751M
December 31, 2016 0.624M
September 30, 2016 1.142M
June 30, 2016 -0.2191M
March 31, 2016 0.7435M
December 31, 2015 1.214M
September 30, 2015 1.046M
June 30, 2015 1.251M
March 31, 2015 1.810M
December 31, 2014 1.577M
September 30, 2014 0.419M
June 30, 2014 1.593M
March 31, 2014 0.8922M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
The Estée Lauder Companies, Inc. 576.00M
Edgewell Personal Care Co. 118.70M
Interparfums, Inc. 45.58M
Coty, Inc. 116.00M
BioForce Nanosciences Holdings, Inc. -0.027M